Neuromuscular disease specialist and professor of neurology at the University of Kansas Medical Center.
Positive Impact of Ataluren on Walking Ability in Duchenne Muscular Dystrophy: Jeffrey M. Statland, MD
At the 2023 AAN Annual Meeting, the neuromuscular disease specialist and professor of neurology at the University of Kansas Medical Center talked about the phase 3 study investigating ataluren for Duchenne muscular dystrophy. [WATCH TIME: 5 minutes]
NeurologyLive® Friday 5 — May 2, 2025
The Growing Role of AI in Neurology
Evolving Clinical Insights Into Neuroimmune Mechanisms and Multiple Sclerosis Progression
Improving CSAI Adherence and Its Evolving Role in PD